Destiny Pharma plc

AIM:DEST 株式レポート

時価総額：UK£4.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Destiny Pharma マネジメント

マネジメント 基準チェック /34

Destiny Pharmaの CEO はChris Toveyで、 Sep2023年に任命され、 の在任期間は 1 年未満です。 の年間総報酬は£ 123.00Kで、 89.4%給与と10.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.042%を直接所有しており、その価値は£ 1.90K 。経営陣と取締役会の平均在任期間はそれぞれ3.4年と6.3年です。

主要情報

Chris Tovey

最高経営責任者

UK£123.0k

報酬総額

CEO給与比率89.4%
CEO在任期間less than a year
CEOの所有権0.04%
経営陣の平均在職期間3.4yrs
取締役会の平均在任期間6.3yrs

経営陣の近況

Recent updates

We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Jan 12
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Destiny Pharma (LON:DEST) Is In A Good Position To Deliver On Growth Plans

Sep 26
Destiny Pharma (LON:DEST) Is In A Good Position To Deliver On Growth Plans

We Think Destiny Pharma (LON:DEST) Needs To Drive Business Growth Carefully

May 26
We Think Destiny Pharma (LON:DEST) Needs To Drive Business Growth Carefully

Companies Like Destiny Pharma (LON:DEST) Are In A Position To Invest In Growth

Feb 01
Companies Like Destiny Pharma (LON:DEST) Are In A Position To Invest In Growth

Will Destiny Pharma (LON:DEST) Spend Its Cash Wisely?

Aug 05
Will Destiny Pharma (LON:DEST) Spend Its Cash Wisely?

Is Destiny Pharma (LON:DEST) In A Good Position To Invest In Growth?

Apr 16
Is Destiny Pharma (LON:DEST) In A Good Position To Invest In Growth?

What Type Of Shareholders Make Up Destiny Pharma plc's (LON:DEST) Share Registry?

Feb 11
What Type Of Shareholders Make Up Destiny Pharma plc's (LON:DEST) Share Registry?

We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

Nov 30
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely

CEO報酬分析

Destiny Pharma の収益と比較して、Chris Tovey の報酬はどのように変化したか？
日付総報酬給与会社業績
Dec 31 2023UK£123kUK£110k

-UK£6m

報酬と市場: Chrisの 総報酬 ($USD 158.25K ) は、 UK市場 ($USD 356.31K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Chrisの報酬と会社の業績を比較するにはデータが不十分です。

CEO（最高経営責任者

Chris Tovey (59 yo)

less than a year

在職期間

UK£123,000

報酬

Mr. Christopher John Tovey, also known as Chris, BSc, serves as Chief Executive Officer & Director of Destiny Pharma plc since September 1, 2023. He had been the Chief Operating Officer at GW Pharmaceutica...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christopher Tovey
CEO & Directorless than a yearUK£123.00k0.042%
£ 1.9k
William Love
Founder27.6yrsUK£250.00k6.8%
£ 309.2k
Shaun Claydon
CFO, Company Secretary & Director5.8yrsUK£270.00k0.025%
£ 1.2k
Debra Barker
Interim CMO & Senior Independent Directorless than a yearUK£213.00k0.092%
£ 4.2k

3.4yrs

平均在職期間

60.5yo

平均年齢

経験豊富な経営陣: DESTの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Christopher Tovey
CEO & Directorless than a yearUK£123.00k0.042%
£ 1.9k
William Love
Founderno dataUK£250.00k6.8%
£ 309.2k
Shaun Claydon
CFO, Company Secretary & Director5.8yrsUK£270.00k0.025%
£ 1.2k
Debra Barker
Interim CMO & Senior Independent Director4.6yrsUK£213.00k0.092%
£ 4.2k
Anthony Nigel Rudd
Independent Chairman8yrsUK£34.00k3.93%
£ 178.7k
Richard Proctor
Member of Scientific Advisory Board6.3yrsデータなしデータなし
Nigel Brooksby
Non-Executive Director2.2yrsUK£41.00k0.36%
£ 16.6k
Vance Fowler
Member of Scientific Advisory Board6.3yrsデータなしデータなし
David Roblin
Chair of the Scientific Advisory Board6.3yrsUK£10.66kデータなし
Leonard Mermel
Member of Scientific Advisory Board6.3yrsデータなしデータなし
Glenn J. Whitman
Member of Scientific Advisory Board6.3yrsデータなしデータなし
E Dellinger
Member of Scientific Advisory Boardno dataデータなしデータなし

6.3yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: DESTの 取締役会 は 経験豊富 であると考えられます ( 6.3年の平均在任期間)。